# HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

> **NCT03282474** · PHASE2 · COMPLETED · sponsor: **Hannover Medical School** · enrollment: 10 (actual)

## Conditions studied

- Hepatitis E
- Hepatitis Chronic Viral

## Interventions

- **DRUG:** Sofosbuvir

## Key facts

- **NCT ID:** NCT03282474
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-07
- **Primary completion:** 2018-11-26
- **Final completion:** 2019-02-18
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-03-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282474, "HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03282474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*